1. Review current treatment guidelines for advanced urothelial carcinoma

2. Discuss clinical evidence of immunotherapy for advanced urothelial carcinoma

and

1.     Gained a deeper knowledge of the evolution of tumor boards

2.     Better understand the diversity of perceived purposes of tumor boards

3.     Improve their grasp of data supporting the use of tumor boards

Session date: 
Monday, January 28, 2019 - 12:00pm to 1:00pm
Speaker Name: 
Carolina Soto Chervin, MD, PhD and Garth W. Strohbehn, MD, Phil
Location: 
UCMC
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.